FOXO1 and type 1 diabetes mellitus: Consistent with these findings, our group first demonstrated that suppression of FoxO1 might attenuate vascular remodeling induced by type 1 diabetes in rats through decreasing the expression of NLRP3 inflammasome activation and activating related underlying mechanism including PDK1/FoxO1 pathway (14).